ReportsnReports.com offers “European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017” research report in its store.
The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes.
The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries and infections and development of alternate delivery methods are restraining the growth of the market.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=258083.
Germany accounted for the largest market share of the European injectable drug delivery technologies market in 2012, followed by France. While Germany is a mature market experiencing a surge in biologics and high incidence of chronic diseases, France is the fastest-growing region. This is due to high insurance coverage for injectable devices and formulations, affordability for healthcare expenses, and activities such as exhibitions and conferences hosted by France that address injectable drug delivery technologies. The other European regions of Spain, Italy and Russia show high export potential for plastic syringes and needle, rising support for generics market, and increasing expenditure in the healthcare sector. The regions of Switzerland, Denmark, Ireland, Greece, Hungary, the Netherlands, Poland, Portugal, Romania, and Ukraine provide benefits such as favorable environment for research and development, growth in diabetic expenditures, and favorable reimbursement policies for injectable devices.
The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG (Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and Owen Mumford, Ltd. (U.K.).
Inquire for a discount on this report @ http://www.reportsnreports.com/contacts/Discount.aspx?name=258083.
Scope of the Report
This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario.
Europe Injectable Drug Delivery Technologies Market, By Segment
- Injectable Drug Delivery Devices Technologies
- Injectable Drug Delivery Formulations Technologies
Europe Injectable Drug Delivery Devices Technologies Market, By Product: Conventional Injection Devices, By Materials, Glass, Plastics, By Products, Fillable Syringes, Prefilled Syringes, By Usability, Reusable, Disposable, Self-Injection Devices, Needle Free Injectors, By Product, Fillable Syringes, Prefilled Syringes, By Technology, Jet-based Needle Free Injectors, Spring-based Needle Free Injectors, Laser Powered Needle Free Injectors, Others, By Usability, Reusable, Disposable, ,Auto Injectors ,By Products , Fillable Syringes, Prefilled Syringes, By Technology, Manual Injection Auto Injectors, Automated Injection Auto Injectors, By Design, Standardized Auto Injectors, Customized Auto Injectors, By Usability, Reusable, Disposable, Pen Injectors, By Products, Single Chambered Pen Injectors, Dual Chambered Pen Injectors, By , Design, Standardized pen injectors, Customized pen injectors, By usability, Reusable, DisposableOthers (blunt-needle, micro needle, and nano needle injections)
Europe Injectable Drug Delivery Formulations Technologies, By Product: Conventional Drug Delivery Formulations, Solution, Reconstituted / Lyophilized Formulations, Novel Drug elivery Formulations, Liposomal Systems, Microspheres, Nanoparticles, Polymeric Micelles, Others (dendrimers, nanosponge, and nanoemulsions)
Europe Injectable Drug Delivery Technologies Market, By Therapeutic Applications: Auto-immune Diseases, Multiple Sclerosis, Rheumatoid Arthritis, ,Crohn's Diseases ,Psoriasis, Others, Hormonal Disorders, Diabetes, Antithrombotic/Thrombolytic Therapy, Reproductive Health Diseases, Anemia, Osteoporosis, Others, Orphan Diseases, Oncology, Others, Pain Management, Allergies, Hepatitis C, Aesthetic Treatment
Europe Injectable Drug Delivery Technologies Market, By Geography: Germany, France, U.K., ,Spain Italy, ,Russia ,Rest of Europe
Complete report available at http://www.reportsnreports.com/reports/258083-european-injectable-drug-delivery-market-by-formulations-liposomes-microspheres-nanoparticles-devices-disposables-reusable-fillable-prefilled-pen-needle-free-auto-injectors-therapeutics-diabetes-oncology-forecasts-to-2017.html.
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on email@example.com and we would be happy to help you find the business intelligence that you need. Not limited to the Biotechnology (http://www.reportsnreports.com/market-research/biotechnology/) industry, ReportsnReports.com offers research studies on agriculture, medical devices, chemicals, environment, energy and power, consumer goods, pharmaceuticals, automotive, water and much more.